Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1SANOFI AVENTIS US
02 1DR REDDYS
03 6DR REDDYS LABS SA
04 2ETHYPHARM USA CORP
05 4ABRAXIS PHARM
06 2ACCORD HLTHCARE
07 2ACTAVIS ELIZABETH
08 1ACTAVIS LABS UT INC
09 3ADAPT
10 2ALKEM LABS LTD
11 4ALVOGEN
12 1AMNEAL
13 2AMNEAL PHARMS
14 1AMPHASTAR PHARMS INC
15 1ASTRAZENECA
16 2BAXTER HLTHCARE CORP
17 3BDSI
18 1BPI LABS
19 3BRISTOL MYERS SQUIBB
20 1CHARTWELL RX
21 2DIFGEN PHARMS
22 2EMERGENT
23 1ENDO OPERATIONS
24 3EUGIA PHARMA
25 2FRESENIUS KABI USA
26 1HARM REDUCTION THERP
27 12HIKMA
28 8HOSPIRA
29 12IGI LABS INC
30 6INDIVIOR
31 4INTL MEDICATION
32 3KALEO INC
33 2LANNETT CO INC
34 1LUPIN
35 1MANKIND PHARMA
36 1MARSAM PHARMS LLC
37 2MYLAN INSTITUTIONAL
38 1MYLAN LABS LTD
39 4MYLAN TECHNOLOGIES
40 6OREXO US INC
41 1PADAGIS ISRAEL
42 1PAR STERILE PRODUCTS
43 3PURDUE PHARMA LP
44 3QUAD PHARMS
45 2RHODES PHARMS
46 2RISING
47 3SMITH AND NEPHEW
48 2SOLOPAK
49 2SOMERSET THERAPS LLC
50 2SPECGX LLC
51 1SUMMIT BIOSCI
52 2SUN PHARM
53 1SUN PHARM INDS LTD
54 6SUN PHARM INDUSTRIES
55 4TEVA PHARMS USA
56 2WATSON LABS
57 2WES PHARMA INC
58 4WYETH AYERST
59 1ZMI PHARMA
01 3FILM;BUCCAL
02 19FILM;BUCCAL, SUBLINGUAL
03 1FILM;SUBLINGUAL
04 77INJECTABLE;INJECTION
05 3Injectable; Injection
06 4SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
07 7SPRAY, METERED;NASAL
08 2SPRAY;NASAL
09 3TABLET, EXTENDED RELEASE;ORAL
10 4TABLET;ORAL
11 38TABLET;SUBLINGUAL
01 69DISCN
02 5OTC
03 77RX
04 10Blank
01 3BUNAVAIL
02 44BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
03 1BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
04 1CASSIPA
05 1EVZIO
06 1EVZIO (AUTOINJECTOR)
07 1KLOXXADO
08 7NALOXONE
09 3NALOXONE HCL
10 67NALOXONE HYDROCHLORIDE
11 1NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
12 3NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
13 8NARCAN
14 1REXTOVY
15 1REZENOPY
16 1RIVIVE
17 6SUBOXONE
18 1TALWIN NX
19 3TARGINIQ
20 1ZIMHI
21 6ZUBSOLV
01 119No
02 32Yes
03 10Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RLD : No
TE Code :
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE
Brand Name : TALWIN NX
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 0.5MG BASE;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-12-16
Application Number : 18733
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : FILM;BUCCAL, SUBLINGUAL
Dosage Strength : EQ 2MG BASE;EQ 0.5MG BASE
Approval Date : 2018-06-14
Application Number : 205299
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.
RLD : No
TE Code : AB
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : TABLET;SUBLINGUAL
Dosage Strength : EQ 2MG BASE;EQ 0.5MG BASE
Approval Date : 2015-10-16
Application Number : 204431
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : FILM;BUCCAL, SUBLINGUAL
Dosage Strength : EQ 8MG BASE;EQ 2MG BASE
Approval Date : 2018-06-14
Application Number : 205299
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : FILM;BUCCAL, SUBLINGUAL
Dosage Strength : EQ 4MG BASE;EQ 1MG BASE
Approval Date : 2018-06-14
Application Number : 205806
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : FILM;BUCCAL, SUBLINGUAL
Dosage Strength : EQ 12MG BASE;EQ 3MG BASE
Approval Date : 2018-06-14
Application Number : 205806
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : TABLET;SUBLINGUAL
Dosage Strength : EQ 2MG BASE;EQ 0.5MG BASE
Approval Date : 2020-07-17
Application Number : 206953
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : TABLET;SUBLINGUAL
Dosage Strength : EQ 8MG BASE;EQ 2MG BASE
Approval Date : 2020-07-17
Application Number : 206953
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AP
Brand Name : NALOXONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/ML
Approval Date : 2020-03-16
Application Number : 213209
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.
RLD : No
TE Code : AB
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Brand Name : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : TABLET;SUBLINGUAL
Dosage Strength : EQ 8MG BASE;EQ 2MG BASE
Approval Date : 2015-10-16
Application Number : 204431
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
LOOKING FOR A SUPPLIER?
